Market Research Logo

Worldwide Market for Cancer Therapeutics


Attention: There is an updated edition available for this report.

  • Executive Summary
    • INTRODUCTION
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
      • Table World Market for Cancer Therapies Revenues and Growth Rates 2002-2009
      • Table SIZE AND GROWTH OF THE MARKET
    • ISSUES AND TRENDS AFFECTING MARKET
    • LEADING COMPETITORS
  • Introduction
    • WHAT IS CANCER?
      • Biochemistry of Cancer Cells
      • Carcinogen Metabolism
      • Causes of Cancer Growth
        • Table Viruses Associated with Cancer in Humans
    • HISTORY AND GROWTH OF THE CANCER TREATMENT MARKET
    • INDUSTRY STRUCTURE
    • DEMOGRAPHICS AND STATISTICS
      • Table Estimated and Projected World Cancer Incidence by Most Common Types of Cancer, 2003 and 2020
      • Table Estimated and Projected World Cancer Mortality by Most Common Types of Cancer, 2003 and 2020
      • Table World Population by Selected Geographical Region, 2003–2050
      • Table Estimated World Population by Age and Geographical Region 2003
      • Table Life Expectancy at Birth by Selected Countries, 2000
      • Table United States Life Expectancy at Birth, 1990-2000, and Projections, 2005-2010
    • DESCRIPTION OF CANCERS WITH AVAILABLE PRODUCTS
      • Bladder Cancer
      • Breast Cancer
      • Cervical Cancer
      • Colorectal Cancer
      • Esophageal Cancer
      • Head and Neck
      • Kidney
      • Leukemia
        • Table Types of Leukemia, Incidence, Characteristics, Manifestations
      • Liver
      • Lung Cancer
        • Table Types of Primary Lung Cancer, Risk Factors
      • Lymphoma
        • Table Classification of Non-Hodgkin's Lymphomas
      • Melanoma
        • Table Malignant Conditions of the Skin
      • Multiple Myeloma
      • Neuroblastoma
      • Ovarian Cancer
      • Pancreas
      • Prostate Cancer
      • Stomach Cancer
        • Table Estimated World Incidence and Mortality of Cancers with Available Products (thousands)
  • Chemotherapy
    • ALKYLATING AGENTS
      • Nitrogen Mustards
      • Cisplatin
    • ANTIMETABOLITES
      • Cytosine Arabinoside
      • 5-Fluorouracil (5-FU)
      • Hydroxyurea
      • Mercaptopurine and Thioguanine
      • Methotrexate
    • CYTOTOXIC ANTIBIOTICS
      • Actinomycin D
      • Daunorubicin and Doxorubicin
      • Bleomycins
    • PLANT DERIVATIVES
      • Etoposide and Teniposide
      • Vincristine and Vinblastine
    • DESCRIPTION OF PRODUCTS
      • Alkalyting Agents
        • Table Currently Marketed Alkylating Agents (Brand Name , Generic Name, Manufacturers, Uses)
      • Antimetabolites
        • Table Currently Marketed Antimetabolites
      • Cytotoxic Antibiotics
        • Table Currently Marketed Cytoxic Antibiotics
      • Plant Derivatives
        • Table Currently Marketed Plant Derivatives
    • RESEARCH AND DEVELOPMENT
      • New Approvals
        • Table Newly Approved Chemotherapy Agents
      • Products in Development
        • Table Chemotherapy Drugs in the Pipeline
    • MARKET SIZE AND GROWTH
      • Table World Market for Chemotherapy Products in Cancer Revenues and Growth Rates 2002-2009
      • Table MARKET SIZE AND GROWTH
      • Table Estimated Chemotherapy Products Sales by Cancer Type 2004
      • Table Estimated Chemotherapy Product Sales by Region 2004
    • COMPETITIVE ANALYSIS
      • Table Estimated Leading Suppliers' Revenues and Shares of the World Chemotherapy Market 2004
      • Table Top Chemotherapy Products Estimated Sales and Market Share in Cancer 2004
  • Hormone Therapy
    • CORTICOSTEROIDS
    • HORMONE AGONISTS AND ANTAGONISTS
      • Estrogens
      • Androgens
      • Antiestrogens
      • Antiandrogens
      • Gonadotropin-Releasing Hormone Analogues
    • AROMATASE INHIBITORS
    • SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS)
    • DESCRIPTION OF PRODUCTS
      • Corticosteroids
        • Table Currently Marketed Corticosteroids
      • Hormone Agonists and Antagonists
        • Table Currently Marketed Hormone Agonists and Antagonists
      • Aromatase Inhibitors
        • Table Currently Marketed Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
        • Table Currently Marketed Selective Estrogen Receptor Modulators
    • RESEARCH AND DEVELOPMENT
      • Table Cancer Hormone Therapy in Development
    • MARKET SIZE AND GROWTH
      • Table World Market for Hormone Therapy Products in Cancer Revenues and Growth Rates 2002-2009
      • Table MARKET SIZE AND GROWTH
      • Table Estimated Hormone Therapy Products Sales by Cancer Type 2004
      • Table Estimated Hormone Therapy Product Sales by Region 2004
    • COMPETITIVE ANALYSIS
      • Table Estimated Leading Suppliers' Revenues and Shares of the World Hormone Therapy Market 2004
      • Table Top Hormone Therapy Products Estimated Sales and Market Share in Cancer 2004
  • Immunotherapy/Biotherapy
    • MONOCLONAL ANTIBODIES
    • INTERLEUKINS/INTERFERONS
    • VACCINES
    • OTHER BIOTHERAPY
      • Antisense Oligonucleotides
      • Apoptosis
      • Growth Factors
      • Methylation
      • P53
      • Ras Protein Drugs
      • Regulatory Enzymes
    • DESCRIPTION OF PRODUCTS
      • Monoclonal Antibodies
        • Table Currently Marketed Monoclonal Antibodies
      • Interleukins/Interferons
        • Table Currently Marketed Interleukins/Interferons
      • Vaccines
        • Table Currently Approved Cancer Vaccines
      • Other Biotherapy
        • Table Other Biotherapy Currently Marketed for Cancer Treatment
    • RESEARCH AND DEVELOPMENT
      • Awaiting Approval
      • Phase III
      • Phase II
      • Phase I
        • Table Cancer Immunotherapy and Biotherapy Products in Development
    • MARKET SIZE AND GROWTH
      • Table World Market for Biotherapy and Immunotherapy Products in Cancer Revenues and Growth Rates 2002-2009
      • Table MARKET SIZE AND GROWTH
      • Table Estimated Biotherapy and Immunotherapy Products Sales by Cancer Type 2004
      • Table Estimated Immunotherapy/Biotherapy Product Sales by Region 2004
    • COMPETITIVE ANALYSIS
      • Table Estimated Leading Suppliers' Revenues and Shares of the World Immunotherapy and Biotherapy Market 2004
      • Table Top Immunotherapy/Biotherapy Products Estimated Sales and Market Share in Cancer 2004
  • Radiation Therapy
    • EFFECTS OF RADIATION
    • RADIOACTIVE ISOTOPES
    • DESCRIPTION OF PRODUCTS
      • Sodium Radiophosphate
      • Sodium Radioiodine
      • Radiopharmaceuticals
        • Table Currently Marketed Radiation Therapy Products
    • RESEARCH AND DEVELOPMENT
      • Table Cancer Radiation Therapy in Development
    • MARKET SIZE AND GROWTH
      • Table World Market for Radiation Therapy Products in Cancer Revenues and Growth Rates 2002-2009
      • Table MARKET SIZE AND GROWTH
      • Table Estimated Radiation Therapy Product Sales by Region 2004
    • COMPETITIVE ANALYSIS
      • Table Estimated Leading Suppliers' Revenues and Shares of the World Radiation Therapy Market 2004
  • Adjunctive Therapies
    • Table Side-Effects Associated with Chemotherapy
    • Table Side-Effects Associated with Radiation Therapy
    • ANTINAUSEANTS AND ANTIEMETICS
      • Table Chemotherapy Agents and Level of Emetic Potential
    • BIOLOGIC RESPONSE MODIFIERS
    • ANTI-INFECTIVES
      • Table Common Infection Sites
    • NARCOTIC ANALGESICS
    • ANTIDEPRESSANTS
    • DESCRIPTION OF PRODUCTS
      • Antinauseants and Antiemetics
        • Table Currently Marketed Antinauseants and Antiemetics
      • Hematopoietic Growth Factors
      • Cytomodulatory Agents
        • Table Currently Marketed Biological Response Modifiers
      • Anti-infectives
        • Table Currently Marketed Antibiotics and Antivirals for Adjunctive Cancer Therapy
        • Table Currently Marketed Antifungals for Adjunctive Cancer Therapy
      • Narcotic Analgesics
        • Table Currently Marketed Narcotic Analgesics for Adjunctive Cancer Therapy
      • Non-Narcotic Analgesics
        • Table Currently Marketed Non-Narcotic Analgesics for Adjunctive Cancer Therapy
      • Antidepressants
        • Table Currenlty Marketed Antidepressants for Adjunctive Cancer Therapy
    • RESEARCH AND DEVELOPMENT
      • Table Adjunctive Cancer Therapies in Development
    • MARKET SIZE AND GROWTH
      • Table World Market for Adjunctive Therapy Products in Cancer Revenues and Growth Rates 2002-2009
      • Table MARKET SIZE AND GROWTH
      • Table Estimated Adjunctive Therapy Product Sales by Region 2004
    • COMPETITIVE ANALYSIS
      • Table Estimated Leading Suppliers' Revenues and Shares of the Adjunctive Therapies Market 2004
      • Table Top Adjunctive Therapy Products Estimated Sales and Market Share in Cancer 2004
  • Issues and Trends
    • INSURANCE AND REIMBURSEMENT ISSUES
    • PERSONALIZED MEDICINE
    • PHARMACOGENOMICS
    • ALLIANCES ACQUISITIONS AND LICENSING AGREEMENTS
    • MARKETING AND DISTRIBUTION TRENDS
    • IMMUNOGENICITY
    • GEOGRAPHICAL TRENDS
      • United States
      • European Union
      • Japan
    • LIFESTYLE AND SOCIAL ISSUES
    • DRUG DELIVERY ADVANCEMENTS
    • INDIVIDUALIZED CHEMOTHERAPY
    • CHEMOTHERAPY AND MEMORY LOSS
    • ELDERLY CLINICAL TRIAL INVOLVEMENT
    • THALIDOMIDE CONTROVERSY
    • EARLY DETECTION AND SCREENING
      • Table Cancer Detection Tests
    • NEW APPLICATION FOR TOBACCO PLANT
    • FUTURE BUSINESS STRATEGIES
      • Table Competitive Strategies of Biotech Companies
  • Market Summary and Forecast
    • TOTAL MARKET SIZE AND FORECAST
      • Table World Market for Cancer Therapies Revenues and Growth Rates 2002-2009
      • Table TOTAL MARKET SIZE AND FORECAST
      • Table World Market for Cancer Therapies by Type 2002-2009
      • Table TOTAL MARKET SIZE AND FORECAST
  • Corporate Profiles
    • INTRODUCTION
    • AMGEN, INC.
    • ASTRAZENECA PLC
    • BIOGEN IDEC, INC.
    • BRISTOL-MYERS SQUIBB COMPANY/ONCOLOGY
    • CHIRON CORPORATION
    • ELI LILLY & COMPANY
    • GE HEALTHCARE
    • GENENTECH, INC.
    • GLAXOSMITHKLINE PLC
    • JOHNSON & JOHNSON GROUP
    • MERCK & COMPANY, INC.
    • NOVARTIS PHARMACEUTICALS CORPORATION
    • PFIZER, INC.
    • ROCHE
    • SANOFI-AVENTIS
    • SCHERING-PLOUGH CORPORATION
    • TAP PHARMACEUTICAL PRODUCTS, INC.
    • THERAGENICS CORPORATION
  • Company Directory

The world market for cancer therapeutics is growing at a brisk double-digit pace, with revenues surpassing $40 billion this year. This study looks at each therapeutic approach in turn, reporting and forecasting revenues from 2002 through 2009. Market share by leading competitor in each therapy type is estimated for the year 2004. Therapy types considered, include:

  • Chemotherapy
  • Hormone Therapy
  • Radiation Therapy
  • Immunotherapy and Biotherapy, and
  • Adjunctive Therapies

The study focuses on current and emerging markets, products in development, and trends affecting the cancer treatment market. Demographic and epidemiological data are presented for the major cancer types, therapies in development are reviewed by development stage and earliest possible approval date, and profiles of the leading and significant competitors are included for reference.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

All market data pertain to the world market at the manufacturers’ level. The base year for data was 2004. Historical data was provided for the years 2002 and 2003, with forecast data provided for 2005 through 2009. Compound annual growth rates (CAGRs) are provided for the 2002-2004, 2004-2009 and 2002-2009 periods for each industry segment covered. Competitive analysis is provided for the year 2004. The forecasted market analysis for 2005-2009 was based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;